World Conference on Vaccine and Immunology November 21-22, 2019 MENA Plaza Hotel Albarsha | Dubai, UAE

Mr. Adrian Ionel is the Director General at Compania Nationala Unifarm, Romania. He completed his master degree from Academia Nationala de Informatii "Mihai Viteazu". He was the student of Psichology in Universitatea „Spiru Haret” din București.

Pharmasector

Sayed Attar is a veterinary pathologist with extensive experience in diagnostic pathology as well as pathobiology. He has experience in anatomical pathology, in-situ hybridization, immunohistochemistry, and cytogenetics. He is the professor in the Department of Pathology at the College of Veterinary Medicine, Zagazig University, Egypt. He has a strong interest in the training of our graduate students and he has served in the last 15 years on 12 Ph.D. and 15 MS graduate student committees, on all of these as chair and primary mentor. Furthermore, he is the visitor professor to Fac.of Vet.Med.Tripoli University, Libya, since September 2005 up to July ,2015 .

His interest focuses on diagnostic pathology, immunopathology, cytopathology, pathobiology and the pathogenesis of viral, bacterial and fungal diseases as well as cancer pathology, both in animals and inhuman. His work has focused on incorporating education in veterinary medicine and pathology with training in human biomedical research.

Founder & Owner, Mollie J. Holter has over 20 years of Microbiology experience. From the lab bench, to managing teams of scientists and engineers at leading Medical Device companies, she has a proven track record of using her strong technical background to drive biotech innovation forward while ensuring product efficacy and patient safety.

Mollie brings subject matter expertise including:​ Microbiology, sterilization, biocompatibility, toxicology, regulatory requirements, international standards, risk management, material/product requirement specifications, MDR compliance, CAPAs, & verification/validation.

PBC Fellow at HUJI, Israel, Humboldt Postdoctoral Fellow at HZI, Germany (Past), CNPq Fellow, USP, SP, Brazil (Past)

Immunohistochemistry, Protein Chemistry, Bioinformatics, Assay Development, ELISA, Animal Models

Dr. Weisman has been a research and practicing neonatologist for over 35 years. With more than 250 peer-reviewed publications, he is globally recognized for his work with newborns and infectious disease, and has been the lead investigator in multiple international studies.

Dr. Weisman has been working with Group B Strep for almost 40 years, and for the past decade with Ureaplasma, micro-bacteria, which has been difficult to diagnose and treat, until now. His clinical and laboratory discoveries with IVIG led to the success of MedImmune, which sold for $15.6 Bln in 2007.

Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President Foundation de Beaumont Bonelli for Cancer Research. His basic researches have been concerned with antigens induced early during the replication cycle of human herpesviruses. Another study has involved the identification, isolation and characterization of specific virus-induced tumour antigens, which were the "finger-prints" left behind in human cancer.Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor-associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.

His researches have been concerned with the characterization of specific virus-induced tumour antigens, which were the "finger-prints" left behind in human cancer. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor-associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.